CSP Inc. (CSPI) — Q1 FY2024 Form 10-Q
Reporting period: Three months ended December 31, 2023; unaudited. Unless stated otherwise, amounts below are in U.S. dollars. CSPi provides IT integration and managed services, cybersecurity products, network adapters, and high-performance computing systems through its Technology Solutions (TS) and High Performance Products (HPP) segments.
Financial performance and liquidity
| Metric | Q1 FY2024 | Q1 FY2023 |
|---|---|---|
| Revenue | $15.38 million | $18.34 million |
| Gross profit / margin | $4.10 million / 27% | $5.82 million / 32% |
| Operating income (loss) / margin | $(0.34) million / (2%) | $1.36 million / 7% |
| Net income (loss) | $(0.07) million | $0.96 million |
| Net income (loss) per common share, diluted | $(0.02) | $0.21 |
| Operating cash flow | $1.67 million | $(4.23) million |
Cash and cash equivalents were $25.61 million at December 31, up from $25.22 million at September 30, 2023. Current assets were $53.62 million and current liabilities $16.98 million. The company reported $0.76 million outstanding on its $15 million inventory line of credit, with $14.2 million available, and no note payable after repaying the remaining balance during the quarter. It was in compliance with the line’s financial covenants. Total shareholders’ equity was $46.47 million.
Operating cash flow improved year over year, principally due to changes in accounts payable and accrued expenses, partly offset by inventory purchases. This is a working-capital-driven comparison; inventory increased $4.42 million from September 30, while accounts payable and accrued expenses increased $3.17 million on the balance sheet. Investing cash outflow was $0.13 million and financing cash outflow was $1.18 million. A $0.04-per-share dividend was declared, totaling approximately $0.19 million.
Changes versus the prior comparable period
- Revenue declined $2.97 million, or 16%. TS sales fell 8% to $14.66 million; HPP sales fell 71% to $0.71 million.
- TS product sales were lower by $1.12 million, mainly from decreased sales to several major U.S. customers. HPP product sales were lower by $1.69 million, largely because a large Myricom order in the prior-year quarter did not recur.
- Gross margin fell five percentage points to 27%. TS margin remained 26%; HPP margin declined from 66% to 47%, reflecting prior-year order mix and lower royalty sales.
- Operating results shifted from $1.36 million income to a $0.34 million loss. SG&A rose 3% to $3.74 million while engineering and development expense declined to $0.70 million.
- Other income, net improved by $0.55 million to $0.28 million, primarily due to a smaller foreign-exchange loss and higher interest income. The quarter still ended with a net loss.
Outlook, management commentary, and risks
- Management said available cash, expected operating cash generation, and line-of-credit availability should meet working-capital and capital-expenditure needs for at least 12 months from the filing date. No specific revenue or earnings guidance was provided.
- Management cited customer concentration and dependence on U.S. federal government contracts, competition, tax-law changes, and geopolitical and pandemic-related uncertainty as risks. It reported no direct significant revenue impact to date from the Russia-Ukraine or Israel-Hamas conflicts, but noted potential indirect impacts through suppliers, customers, cyberattacks, supply disruptions, demand, and currency or financial markets.
- One customer represented 17% of quarterly revenue. Financing receivables were $9.95 million net, with substantial exposure to a small number of customers; one customer represented 61% of the balance.
- The company adopted the CECL expected-credit-loss standard on October 1, 2023. The transition reduced opening retained earnings by $15,000; the company recorded a $77,000 allowance against financing receivables at quarter-end. Management reported no material changes to the risk factors in its FY2023 Form 10-K.
- Management identified no material change to internal control over financial reporting other than controls updated for CECL adoption, and concluded disclosure controls were effective.
Important facts for investors to verify
- Whether subsequent TS customer demand and HPP order activity offset the quarter’s 16% revenue decline and margin compression.
- Whether the improved operating cash flow is sustained, given its dependence on working-capital timing and the sharp inventory increase.
- Customer concentration and collectability of financing receivables, including the CECL allowance assumptions and major-customer exposures.
- Remaining vendor-payment obligations associated with customer financing arrangements and continued compliance with line-of-credit covenants.
- Any updates to management’s 12-month liquidity assessment, dividend policy, or risks from geopolitical and supply-chain developments.